4-aminopyridine has been researched along with almokalant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Barajas, H; Elizalde, A; Navarro-Polanco, R; Sánchez-Chapula, J | 1 |
2 other study(ies) available for 4-aminopyridine and almokalant
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Frequency-dependent effects of 4-aminopyridine and almokalant on action-potential duration of adult and neonatal rabbit ventricular muscle.
Topics: 4-Aminopyridine; Action Potentials; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Electric Stimulation; Heart Ventricles; In Vitro Techniques; Membrane Potentials; Muscles; Papillary Muscles; Potassium Channels; Propanolamines; Rabbits; Ventricular Function | 1999 |